Managed Healthcare Executive

Brian Evanko to be Cigna CEO starting in July

Brian Evanko will assume CEO duties July 1, 2026 after overseeing Cigna Healthcare and Evernorth, signaling continuity in ...
Managed Healthcare Executive

With a PDUFA date on the horizon, another trial of Afrezza begins

The May 29, 2026 PDUFA targets pediatric approval of Afrezza for type 1 or type 2 diabetes, leveraging INHALE-1 outcomes versus rapid-acting analogs plus basal insulin. INHALE-1 was open-label and ...
Managed Healthcare Executive

A Q&A with Zahra Mahmoudjafari on building successful cell and gene therapy programs

Zahra Mahmoudjafari explains how cell and gene therapy programs succeed with strong infrastructure, pharmacy leadership, ...
Managed Healthcare Executive

NGS-based detection of circulating HPV DNA offers promise for monitoring for early recurrence of cervical cancer

A custom NGS panel covering 27 IARC carcinogenic HPV genotypes enabled detection of ccfHPV DNA across treatment strata and ...
Managed Healthcare Executive

Low vitamin D tied to hospitalizations from respiratory tract infections

The results show that those with low vitamin D levels had a significantly higher risk of hospitalization related to respiratory tract infection compared with those whose 25 (OH)D levels were 75 nmol/L ...
Managed Healthcare Executive

Analysis reinforces benefit and safety of adjuvant Keytruda for stage 2 melanoma

A secondary analysis of the phase 3 KEYNOTE-716 trial finds that adjuvant Keytruda improves recurrence-free survival without increasing the risk of new primary melanoma and may reduce non-melanoma ...